Ertahil Sit 15/100mg Tablet – Ertugliflozin 15mg + Sitagliptin 100mg for Type 2 Diabetes
Ertahil Sit 15/100mg Tablet – Ertugliflozin 15mg + Sitagliptin 100mg for Type 2 Diabetes
Ertahil Sit 15/100mg Tablet – Ertugliflozin 15mg + Sitagliptin 100mg for Type 2 Diabetes
Description
Ertahil Sit 15/100mg Tablet – Powerful Dual-Action Once-Daily Tablet for Better Blood Sugar Control
Ertahil Sit 15/100mg Tablet combines ertugliflozin 15 mg (SGLT2 inhibitor) and sitagliptin 100 mg (DPP-4 inhibitor) to deliver two complementary mechanisms in a single pill for adults with type 2 diabetes. Ertugliflozin removes excess glucose through urine while sitagliptin boosts natural incretin hormones to increase insulin release and reduce liver glucose production only when blood sugar is high. This high-strength combo provides significant HbA1c reduction, modest weight loss, low risk of hypoglycemia, and proven cardiovascular & kidney protection. Ideal for patients not adequately controlled on metformin or other oral agents – once-daily convenience helps improve long-term adherence.
